Skip to main content
FinSpry Logo
FinSpry
TVRD logo
TVRD
(NASDAQ)
Tvardi Therapeutics, Inc.
$1.85-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tvardi Therapeutics (TVRD) Stock Price & Financial Analysis

Tvardi Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.85 - $1.94
52-Week High$43.65
52-Week Low$1.50
Open$1.92
Volume93.95K
Average Volume (3M)222.32K
Market Cap17.92M
Shares Outstanding9.38M
Price to Sales (P/S)6.97
Price to Book (P/B)0.86
EV/EBITDA0.09
Revenue (TTM)2.57M
Net Income (TTM)-26.88M
Free Cash Flow (TTM)-21.49M
EPS (TTM)$-2.87
Profit Margin-1046.36%
Operating Margin-1096.26%
Return on Equity (ROE)-128.33%
Debt to Equity0.01
50-Day MA$2.27
200-Day MA$3.31
52-Week Change-93.46%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tvardi Therapeutics

What is the current stock price for TVRD?

As of the latest trading session, TVRD stock trades at $1.85. The 52-week range is $1.50–$43.65, with a day range of $1.85–$1.94.

What is the P/E ratio for TVRD?

The P/E ratio (Price-to-Earnings) for TVRD is shown in the Key Statistics section. This valuation metric helps compare Tvardi Therapeutics, Inc. to industry peers.

Does TVRD pay dividends?

Tvardi Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TVRD?

Based on 5 analysts, the consensus for TVRD is Buy.

What is the market cap of TVRD?

Tvardi Therapeutics's market capitalization is $17.4M, classifying it as a micro-cap company. Tvardi Therapeutics operates in the Healthcare sector within the Biotechnology industry.